Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aldeyra Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aldeyra Therapeutics Inc (ALDX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

31 Aug 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Rating and Forecast Report for ALDX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Aug 2015 ValuEngine, Inc. 11 $25.00

ALDEXA THERAPEUTICS INC (ALDX) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Aug 2015 Pechala's Reports 1 $15.00

ALDEXA THERAPEUTICS INC (ALDX) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

22 Aug 2015 Pechala's Reports 1 $25.00

ValuEngine Industry Report for Medical-Drugs(ALDX)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

20 Aug 2015 ValuEngine, Inc. 10 $49.00

ALDX 2Q15 - Initiation of Phase IIa trial in allergic conjunctivitis to commence shortly. Logistical issues cause slight delay in SLS and NAU trials. Strong cash position.

This morning, ALDX reported 2Q15 financial results with a net loss of ($2.2MM), vs. Laidlaw ($2.8MM) and the Street ($2.6MM) ...

11 Aug 2015 Laidlaw & Company 8 $25.00

ValuEngine Industry Report for Medical-drugs(ALDX)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

23 Jul 2015 ValuEngine, Inc. 10 $49.00

US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.

29 Jun 2015 Pechala's Reports 83 $1,000.00

ALDX: Management update provided renewed confidence

After recent meeting with ALDX management, we walked away with renewed confidence that the company’s developments are on-trac...

11 Jun 2015 Laidlaw & Company 8 $25.00